Nanobodies and Antivenoms: Microbial Minutes

Nov. 18, 2024

Scientists are coupling microbiology with biotechnology to create snakebite antidotes that overcome limitations of antivenoms.

What's Hot in the Microbial Sciences?

Snakebite envenoming, classified as a neglected tropical disease by the World Health Organization, impacts millions of people every year, leading to thousands of deaths. Antivenoms are effective, but they come with health risks and production and accessibility issues. While microbes are not the cause of this snakebite problem, they are part of the solution. Scientists are marrying microbiology with biotechnology to create snakebite antidotes that overcome some of the limitations of antivenoms. And it goes both ways: researchers aren’t just using microbes to help combat venom—they’re also using venom to combat microbes. Key take-aways and resources used in this Microbial Minutes are listed below.

Key Take-Aways

  • Novel antidotes are needed to treat snakebite envenoming, which harms millions of people every year. 
  • Small antibody fragments, called “nanobodies”—derived from antibodies in animals like camels and alpacas—may be promising tools for mitigating the effects of envenoming. 
  • Phage display technology is useful for determining which nanobodies show highest affinity for snake venoms, and thus highest potential for therapeutic use.  
  • Scientists have also been exploring the antimicrobial potential of venom, or components thereof, from diverse insects and animals.

Resources


We want to hear from you! Please take 2-3 minutes to fill out the survey linked below. Your answers will help us improve future Microbial Minutes. And don't forget to subscribe to ASM's YouTube channel to be notified whenever a new video drops.



Author: Madeline Barron, Ph.D.

Madeline Barron, Ph.D.
Madeline Barron, Ph.D., is the Science Communications Specialist at ASM. She obtained her Ph.D. from the University of Michigan in the Department of Microbiology and Immunology.